
July 15, 2026
Elevance Stumbles A Bit In Q2 But Recovering Elevance Health is kicking off another round of quarterly earnings results for health plans. The results are a mixed bag – with ongoing signs of recovery but signals that challenges and uncertainty remain for big insurers and plans in general. Elevance posted $1.5 billion in profit for Q2 and revenue of $50.5 billion, but profit was down from Q2 2025. Elevance is still meeting guidance to investors (and is upping it), but investors wanted more. Here are some of the troubling signs, which are expected in other big plans too for Q2. Some good news is the settlement on Medicare Advantage (MA) risk adjustment. Elevance will face no sanctions. Additional articles: https://www.fiercehealthcare.com/payers/elevance-healths-stock-slides-premarket-even-it-beats-street-15b-q2-profit and https://www.modernhealthcare.com/insurance/mh-elevance-health-earnings-state-medicaid-markets/ and https://www.healthcaredive.com/news/elevance-medicaid-exits-q2-2025-2026-earnings-raise/825217/ and https://www.beckerspayer.com/financial/elevance-reports-1-5b-profit-in-q2-membership-dips/ (Some articles may require a subscription.) #healthplans #margins #medicareadvantage #elevancehealth https://www.modernhealthcare.com/insurance/mh-elevance-earnings-profit-guidance 340B Costs Hit $100 Billion More news that will likely mean regulatory or


